Fisher’s exact test was used for comparison, and the results revealed no statistically significant difference in the incidence of CNS infiltration by leukemia during chemotherapy between the two groups (P = 1.000), indicating that there was no association between CDKN2A/B deletion and CNS infiltration. This evidence concerns the gene CDKN2A and leukemia.